Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783121 | 12778312 | 1 | I | 20160909 | 20160912 | 20160926 | 20160926 | EXP | US-CIPLA LTD.-2016US18369 | CIPLA | 0.00 | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127783121 | 12778312 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | 5 MG, QD | 0 | 5 | MG | TABLET | QD | ||||||
| 127783121 | 12778312 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | 5 MG, 1 TABLET FOR THREE DAYS PER WEEK AND HALF TABLET FOR OTHER DAYS | 0 | 5 | MG | TABLET | |||||||
| 127783121 | 12778312 | 3 | C | TYLENOL | ACETAMINOPHEN | 1 | Unknown | UNK, PRN | U | U | 0 | TABLET | |||||||
| 127783121 | 12778312 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | Unknown | 8 MG, BID | U | U | 0 | 8 | MG | TABLET | BID | ||||
| 127783121 | 12778312 | 5 | C | Amiodarone | AMIODARONE | 1 | Unknown | 200 MG, QD | U | U | 0 | 200 | MG | TABLET | QD | ||||
| 127783121 | 12778312 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 81 MG, UNK | U | U | 0 | 81 | MG | TABLET | |||||
| 127783121 | 12778312 | 7 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | 40 MG, QD | U | U | 0 | 40 | MG | TABLET | QD | ||||
| 127783121 | 12778312 | 8 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 5000 IU, QD | U | U | 0 | 5000 | IU | TABLET | QD | ||||
| 127783121 | 12778312 | 9 | C | COENZYME Q10 | UBIDECARENONE | 1 | Unknown | 300 MG, BID | U | U | 0 | 300 | MG | CAPSULE | BID | ||||
| 127783121 | 12778312 | 10 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | Unknown | 325 MG, BID | U | U | 0 | 325 | MG | TABLET | BID | ||||
| 127783121 | 12778312 | 11 | C | Fish oil | FISH OIL | 1 | Unknown | 1000 MG, QD | U | U | 0 | 1000 | MG | CAPSULE | QD | ||||
| 127783121 | 12778312 | 12 | C | FLUNISOLIDE. | FLUNISOLIDE | 1 | Unknown | 0.025% 2 SPRAYS EVERY 12 HOURS | U | U | 0 | NASAL SPRAY | |||||||
| 127783121 | 12778312 | 13 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 25 MG HALF A TABLET BID | U | U | 0 | TABLET | |||||||
| 127783121 | 12778312 | 14 | C | METOLAZONE. | METOLAZONE | 1 | Unknown | 2.5 MG, 1 TABLET ONCE A WEEK | U | U | 0 | 2.5 | MG | TABLET | |||||
| 127783121 | 12778312 | 15 | C | Levothyroxin | LEVOTHYROXINE | 1 | Unknown | 175 MCG, QD | U | U | 0 | 175 | UG | TABLET | QD | ||||
| 127783121 | 12778312 | 16 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 80 MG, BID | U | U | 0 | 80 | MG | TABLET | BID | ||||
| 127783121 | 12778312 | 17 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG | CAPSULE | QD | ||||
| 127783121 | 12778312 | 18 | C | RIFAMPIN. | RIFAMPIN | 1 | Unknown | 300 MG, 2 CAPSULES BID | U | U | 0 | 300 | MG | CAPSULE | |||||
| 127783121 | 12778312 | 19 | C | Spiranolactone | 2 | Unknown | 25 MG, HALF TABLET QD | U | U | 0 | 25 | MG | TABLET | ||||||
| 127783121 | 12778312 | 20 | C | TERAZOSIN | TERAZOSINTERAZOSIN HYDROCHLORIDE | 1 | Unknown | 2 MG, QD | U | U | 0 | 2 | MG | CAPSULE | QD | ||||
| 127783121 | 12778312 | 21 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | UNK, PRN | U | U | 0 | TABLET | |||||||
| 127783121 | 12778312 | 22 | C | Potassium | POTASSIUM | 1 | Unknown | 20 MCG, HALF TABLET QD | U | U | 0 | 20 | UG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127783121 | 12778312 | 1 | Thrombosis |
| 127783121 | 12778312 | 3 | Pain |
| 127783121 | 12778312 | 4 | Hypersensitivity |
| 127783121 | 12778312 | 5 | Cardiac disorder |
| 127783121 | 12778312 | 6 | Thrombosis |
| 127783121 | 12778312 | 7 | Hypercholesterolaemia |
| 127783121 | 12778312 | 8 | Supplementation therapy |
| 127783121 | 12778312 | 10 | Supplementation therapy |
| 127783121 | 12778312 | 11 | Supplementation therapy |
| 127783121 | 12778312 | 12 | Hypersensitivity |
| 127783121 | 12778312 | 13 | Hypertension |
| 127783121 | 12778312 | 14 | Hypertension |
| 127783121 | 12778312 | 15 | Hypothyroidism |
| 127783121 | 12778312 | 16 | Fluid retention |
| 127783121 | 12778312 | 17 | Reflux gastritis |
| 127783121 | 12778312 | 19 | Hypertension |
| 127783121 | 12778312 | 20 | Hypertension |
| 127783121 | 12778312 | 21 | Pain |
| 127783121 | 12778312 | 22 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127783121 | 12778312 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127783121 | 12778312 | Arthritis infective | |
| 127783121 | 12778312 | International normalised ratio decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127783121 | 12778312 | 1 | 20160901 | 0 |